WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
DDX41 and its unique contribution to myeloid leukemogenesis

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc
Oncology August 03,2024
DDX41 and its unique contribution to myeloid leukemogenesis

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc
Oncology August 03,2024
Researchers learn how cancer cells divide despite treatment

Researchers learn how cancer cells divide despite treatment

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineResearchers first saw evidence that some cells were escaping arrest in the continued presence of Palbociclib just
Oncology August 03,2024
Researchers learn how cancer cells divide despite treatment

Researchers learn how cancer cells divide despite treatment

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineResearchers first saw evidence that some cells were escaping arrest in the continued presence of Palbociclib just
Oncology August 03,2024
Research points the way toward an exhaled-breath test for lung cancer

Research points the way toward an exhaled-breath test for lung cancer

by Hackensack Meridian HealthOlivier Loudig, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI). Credit: Hackensack Meridian HealthThe foundational science to develop an exhal
Oncology August 03,2024
Research points the way toward an exhaled-breath test for lung cancer

Research points the way toward an exhaled-breath test for lung cancer

by Hackensack Meridian HealthOlivier Loudig, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI). Credit: Hackensack Meridian HealthThe foundational science to develop an exhal
Oncology August 03,2024
Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainIn a reportpublishedinNature Cell Biology, researchers at Baylor College of Medicine, Texas Children's Hospita
Oncology August 03,2024
Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainIn a reportpublishedinNature Cell Biology, researchers at Baylor College of Medicine, Texas Children's Hospita
Oncology August 03,2024
And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc
Oncology August 03,2024
And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc
Oncology August 03,2024
Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b
Oncology August 03,2024
Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b
Oncology August 03,2024
Study shows elevated cancer risk for women with endometriosis

Study shows elevated cancer risk for women with endometriosis

byHuntsman Cancer InstituteCredit: CC0 Public DomainA landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at
Oncology August 03,2024
Study shows elevated cancer risk for women with endometriosis

Study shows elevated cancer risk for women with endometriosis

byHuntsman Cancer InstituteCredit: CC0 Public DomainA landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at
Oncology August 03,2024
Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi
Oncology August 01,2024
Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi
Oncology August 01,2024
Study uncovers genetic cancer risks in 550 patients

Study uncovers genetic cancer risks in 550 patients

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainCurrent screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian
Oncology August 01,2024
Study uncovers genetic cancer risks in 550 patients

Study uncovers genetic cancer risks in 550 patients

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainCurrent screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian
Oncology August 01,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com